PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AMAM vs. KAMN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between AMAM and KAMN is 0.10, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

AMAM vs. KAMN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ambrx Biopharma Inc. (AMAM) and Kaman Corporation (KAMN). The values are adjusted to include any dividend payments, if applicable.

AMAM
KAMN

Key characteristics

Fundamentals

Market Cap

AMAM:

$1.77B

KAMN:

$1.31B

EPS

AMAM:

$0.42

KAMN:

$0.28

PE Ratio

AMAM:

66.67

KAMN:

164.25

Returns By Period


AMAM

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

KAMN

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AMAM vs. KAMN — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AMAM
The Risk-Adjusted Performance Rank of AMAM is 9494
Overall Rank
The Sharpe Ratio Rank of AMAM is 9191
Sharpe Ratio Rank
The Sortino Ratio Rank of AMAM is 9494
Sortino Ratio Rank
The Omega Ratio Rank of AMAM is 9494
Omega Ratio Rank
The Calmar Ratio Rank of AMAM is 9797
Calmar Ratio Rank
The Martin Ratio Rank of AMAM is 9393
Martin Ratio Rank

KAMN
The Risk-Adjusted Performance Rank of KAMN is 9090
Overall Rank
The Sharpe Ratio Rank of KAMN is 7676
Sharpe Ratio Rank
The Sortino Ratio Rank of KAMN is 9898
Sortino Ratio Rank
The Omega Ratio Rank of KAMN is 9797
Omega Ratio Rank
The Calmar Ratio Rank of KAMN is 8787
Calmar Ratio Rank
The Martin Ratio Rank of KAMN is 9191
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AMAM vs. KAMN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Ambrx Biopharma Inc. (AMAM) and Kaman Corporation (KAMN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
No data
AMAM
KAMN


Rolling 12-month Sharpe Ratio
AMAM
KAMN

Dividends

AMAM vs. KAMN - Dividend Comparison

Neither AMAM nor KAMN has paid dividends to shareholders.


TTM2023202220212020201920182017201620152014
AMAM
Ambrx Biopharma Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
KAMN
Kaman Corporation
0.43%3.34%3.59%1.85%1.40%1.21%1.43%1.36%1.47%1.76%1.60%

Drawdowns

AMAM vs. KAMN - Drawdown Comparison


AMAM
KAMN

Volatility

AMAM vs. KAMN - Volatility Comparison

The current volatility for Ambrx Biopharma Inc. (AMAM) is 0.00%, while Kaman Corporation (KAMN) has a volatility of 0.41%. This indicates that AMAM experiences smaller price fluctuations and is considered to be less risky than KAMN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


AMAM
KAMN

Financials

AMAM vs. KAMN - Financials Comparison

This section allows you to compare key financial metrics between Ambrx Biopharma Inc. and Kaman Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab